Current Edition

clinical study

BioProtect Launches an International Multi-Center Clinical Study Following FDA investigational Device Exemption (IDE)

FDA has granted investigational Device Exemption approval (IDE) to conduct a pivotal clinical study examining theuse of the ProSpace[TM] Balloon System to prevent rectal toxicity …

Continue Reading →
clinical study

FDA lifts clinical hold on fitusiran

Sanofi Genzyme, the specialty care global business unit of Sanofi, and Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that the …

Continue Reading →